Use of the pill which is now authorized to treat newly infected, at-risk people to prevent severe illness, has however jumped in recent weeks as infections rise
A booster dose of the Omicron-adapted bivalent candidates conferred a 9.1 and 10.9-fold increase in neutralising antibodies against Omicron BA.1, that was circulating last winter
While more than 7 million deaths were likely averted in countries covered by Covax, the WHO-backed distribution program, the research nonetheless highlights the devastation caused by uneven access
Pfizer's is already authorized for those over the age of 5
The US Food and Drug Administration (FDA) said that kid-sized doses of Pfizer-BioNTech's COVID-19 vaccine appear to be safe and effective for children under 5-years-old
The companies point to the risk of new variants and waning immunity that could lead to an increase in demand for additional booster shots in some populations.
On Tuesday, the CDC, citing case reports and concerns that relapsed patients could spread the virus, issued its advisory that Paxlovid users should isolate for a second five days if symptoms rebound
World Economic Forum (WEF) 2022: The initiative by Pfizer was launched at the World Economic Forum Annual Meeting in Davos 2022
Pfizer has announced it is to supply all its current and future patent-protected medicines and vaccines on a not-for-profit basis to 45 lower-income countries and is talking to other big drugmakers
The products, which are widely available in the US and the European Union, include 23 medicines and vaccines that treat infectious diseases, some cancers and rare and inflammatory conditions
Pfizer said that preliminary clinical data showed their three-dose Covid-19 vaccine regimen was 80 per cent effective for children aged between 6 months to 5-years-old
Three doses of Pfizer's COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday.
The US FDA has granted emergency use authorisation for a booster dose of the Pfizer-BioNTech vaccine for children aged between 5-11 years at least 5 months after completion of primary vaccine series
The Covid-19 portfolio contributed 5-6 per cent of Cipla's turnover during peak Covid waves, the firm said
Pfizer will pay $148.50 a share for all of New Haven, Connecticut-based Biohaven's outstanding stock, according to a statement Tuesday
The centre integrates two essential functions under the export-oriented undertaking of Pfizer: Pharmaceutical Sciences (PharmSci) and Global Technology and Engineering (GT&E) Centre of Excellence.
Sales of Pfizer's COVID-19 vaccine and treatment pushed the drugmaker well past expectations in the first quarter, as profit grew 61per cent.
The trial failure, along with reports of rebounding coronavirus levels in some patients who have completed a course of Paxlovid, are unlikely to change the drug's sales potential
'Hire me to run Twitter as VP of Product,' tweeted Nikita Bier, co-founder of a positivity-focused polling app called tbh that was acquired by Meta Platforms
This assumes significance as Covid cases are on the rise in the country, especially in the National Capital Region (NCR)